{"id":126102,"date":"2021-12-10T13:04:04","date_gmt":"2021-12-10T18:04:04","guid":{"rendered":"https:\/\/44.250.171.167\/?p=126102"},"modified":"2022-11-08T02:54:45","modified_gmt":"2022-11-08T07:54:45","slug":"infographic-all-you-need-to-know-about-divis-labs-q3-performance","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/infographic-all-you-need-to-know-about-divis-labs-q3-performance\/","title":{"rendered":"Infographic: All you need to know about Divis Labs Q3 performance"},"content":{"rendered":"\n<p>Divi&#8217;s Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"689\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222-689x1024.jpg\" alt=\"\" class=\"wp-image-126103\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222-689x1024.jpg 689w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222-202x300.jpg 202w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222-768x1141.jpg 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222-1034x1536.jpg 1034w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222.jpg 1280w\" sizes=\"auto, (max-width: 689px) 100vw, 689px\" \/><\/figure>\n\n\n\n<p>The company had net consolidated revenue of \u20b9<strong>2,006<\/strong> crores with a growth of 14% on a yearly basis.<\/p>\n\n\n\n<p>Divis labs had a net profit of <strong>\u20b9<\/strong>606 crores or <strong>\u20b9<\/strong>22.84 per share compared to <strong>\u20b9<\/strong>519 crores or <strong>\u20b9<\/strong>19.57 per share in the same quarter of the previous year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divi&#8217;s Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release The company had net consolidated revenue of \u20b92,006 crores with a growth of 14% on a yearly basis. Divis labs had a net profit of \u20b9606 crores or \u20b922.84 per share compared to \u20b9519 crores or \u20b919.57 per share in the same quarter of the previous [&hellip;]<\/p>\n","protected":false},"author":1738,"featured_media":126103,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,12],"tags":[9138,1408,1115],"class_list":["post-126102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-other-industries","tag-pharma","tag-pharma-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/DivisLabQ222.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":140018,"url":"https:\/\/alphastreet.com\/india\/divis-labs-ltd-nsedivislab-q3-fy23-results-outtotal-income-rises-5-yoy\/","url_meta":{"origin":126102,"position":0},"title":"Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy","author":"Divyansh_Kasana","date":"February 3, 2023","format":false,"excerpt":"Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company operates globally, with facilities in India, the United States, and Europe, and serves customers in over 60 countries. Divi's Laboratories is known for its strong focus on quality\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166064,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2fy25-47-rise-in-profits\/","url_meta":{"origin":126102,"position":1},"title":"Divis Laboratories Ltd Q2FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"December 16, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q2FY25 of \u20b92,338.00 Crores up from \u20b91,909.00 Crore year on year, a rise of 22.47%. Total Expenses for Q2FY25 of \u20b91,722.00 Crores up from \u20b91,526.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169024,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits-2\/","url_meta":{"origin":126102,"position":2},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"July 7, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q4FY25 of \u20b92,585.00 Crores up from \u20b92,303.00 Crore year on year, a rise of 12.24%. Total Expenses for Q4FY25 of \u20b91,807.00 Crores up from \u20b91,669.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167573,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q3fy25-65-rise-in-profits\/","url_meta":{"origin":126102,"position":3},"title":"Divis Laboratories Ltd Q3FY25; 65% rise in Profits","author":"Divyansh_Kasana","date":"March 26, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,319.00 Crores up from \u20b91,855.00 Crore year on year, a rise of 25.01%. Total Expenses for Q3FY25 of \u20b91,675.00 Crores up from \u20b91,461.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164227,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy25-21-rise-in-profits\/","url_meta":{"origin":126102,"position":4},"title":"Divis Laboratories Ltd Q1FY25; 21% rise in Profits","author":"Divyansh_Kasana","date":"September 4, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,118.00 Crores up from \u20b91,778.00 Crore year on year, a rise of 19.12%. Total Expenses for Q1FY25 of \u20b91,593.00 Crores up from \u20b91,367.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156668,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2fy24-29-fall-in-profits\/","url_meta":{"origin":126102,"position":5},"title":"Divis Laboratories Ltd Q2FY24; 29% fall in Profits","author":"Divyansh_Kasana","date":"November 27, 2023","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q2FY24 of \u20b91,909.00 Crores up from \u20b91,855.00 Crore year on year, a rise of 2.91%. Total Expenses for Q2FY24 of \u20b91,526.00 Crores up from \u20b91,320.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-333.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/126102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1738"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=126102"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/126102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/126103"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=126102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=126102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=126102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}